We can't say that there are problems in pharmaceutical factories and hospitals. The terrible thing is that no one seems to have problems, but where are the problems? There is no problem with pharmaceutical companies, because pharmaceutical companies develop this medicine to make money. People are companies, not charities. Even charities need a source of funds. Why would someone spend hundreds of millions or even more money to develop this medicine for nothing, and develop a medicine to sell for tens of dollars a bottle? When can people restore this? There are few patients with rare diseases, and they are sold too cheaply. After the patent protection period, this medicine is worthless.
Of course, the hospital is no problem, because the hospital is a place to see a doctor, and the operation of the hospital also has various costs, whether it is the salary of medical staff, the normal operation and maintenance of the hospital, the cost of medicines and equipment, which all require money. Without money, the hospital can't see you These people who are diagnosed with rare diseases are unfortunate themselves. Of course, they have no problems, but it is embarrassing that everyone has problems without problems, and everyone seems to be doing what they should naturally do. Finally, many patients with rare diseases look down on the disease, which is the disadvantage of market regulation.
Therefore, market regulation has failed and macro-control intervention is needed. In other words, the invisible hand fails to play its role, and the visible hand must be inserted, and the government will regulate it, bring this drug into the scope of medical insurance, and expand the users of this drug. The increase in sales, coupled with the help of medical insurance, can still enable these pharmaceutical companies to maintain basic profit margins, and also enable more diabetics to find hope for life.